Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

Moderna shares surge after it says experimental mRNA cancer treatment passed key test

Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors.

Moderna shares surge after it says experimental mRNA cancer treatment passed key test

We haven't written up this one. PBS NewsHour has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at pbs.org →

More in Health & Medicine

More from Thursday 20 August →